OrthoPediatrics Corp.
KIDS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.18 | 0.02 | -6.11 | 1.32 |
| FCF Yield | -7.72% | -6.24% | -3.87% | -2.52% |
| EV / EBITDA | -54.79 | -85.45 | -93.72 | -159.41 |
| Quality | ||||
| ROIC | -6.03% | -6.38% | 1.87% | -6.08% |
| Gross Margin | 72.58% | 74.80% | 74.14% | 74.86% |
| Cash Conversion Ratio | 0.72 | 1.29 | -17.30 | 0.80 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.74% | 14.90% | 19.83% | 10.56% |
| Free Cash Flow Growth | 10.25% | -44.76% | -9.37% | 2.53% |
| Safety | ||||
| Net Debt / EBITDA | -3.55 | 2.51 | 0.93 | 0.92 |
| Interest Coverage | -11.26 | 0.00 | -8.99 | -7.95 |
| Efficiency | ||||
| Inventory Turnover | 0.48 | 0.35 | 0.40 | 0.43 |
| Cash Conversion Cycle | 778.46 | 992.63 | 847.69 | 781.27 |